Cowen & Co. analyst Jeffrey Osborne maintains Hannon Armstrong (NYSE:HASI) with a Outperform and lowers the price target from $44 to $41.
Lantheus Announces The Approval Of DEFINITY By China’s NMPA
Lantheus Holdings, Inc. (the Company) (NASDAQ:LNTH), a company committed to improving patient outcomes through diagnostics, radiotherapeutics and artificial intelligence solutions that enable clinicians to Find, Fight